Wei Deng

Dr. Wei Deng


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2017 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
QZQing-Yao Zuo
Qing-Yao Zuo
HWHong Wang
Hong Wang
WLWei Li
Wei Li
XNXiao-Hui Niu
Xiao-Hui Niu
YHYan-Hong Huang
Yan-Hong Huang
WDWei Deng
Wei Deng
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by severe hypophosphatemia and osteomalacia. Nonspecific symptoms make the diagnosis elusive. In addition, locating the responsible tumor(s) is challenging. The aim of this study was to investigate the clinical management and outcomes of TIO. The clinical features, diagnostic procedures, treatment, and outcomes of 12 patients were reviewed retrospectively. The cohort comprised six men and six women (mean age 45.5 ± 9.9 years, range 23–61 years). The mean duration of disease was 3.7 ± 2.6 years. All patients manifested progressive bone pain, muscle weakness, and/or difficulty walking. Serum phosphorus concentrations were low in all patients (mean 0.42 ± 0.12 mmol/L). Technetium-99m octreotide scintigraphy was performed in 11 patients and showed lesions in the right distal femur, left femoral head, and right tibial plateau, respectively, in three patients. Magnetic resonance imaging (MRI) was negative for lesions in one patient. Two patients underwent biopsies that showed negative histopathology. Two patients, at 2 years and 8 months, respectively, after having negative technetium-99m octreotide studies, underwent 18F–fluorodeoxyglucose positron emission tomography/computed tomography (CT), which revealed lesions in the sacrum and soft tissue of the left palm, respectively. One tumor was detected by CT and MRI. Overall, lesion sites were the head (two patients, 16.7%), thoracic and lumbar region (two, 16.7%), pelvis (three, 25%), lower limbs (four, 33.3%), and upper limbs (one, 8.3%). All patients underwent surgery, and histopathology showed phosphaturic mesenchymal tumors in each. Postoperatively, serum phosphorus concentrations normalized within 2–7 days in 11 patients. With follow-ups of 1–41 months, surgery was effective in 10 patients. One patient developed local recurrence and another had metastases. Locating tumors responsible for tumor-induced osteomalacia is often challenging. Although complete tumor resection confers a good prognosis in most patients, surveillance for recurrence and metastasis is necessary. Before surgery or when surgery is not indicated, oral phosphate can alleviate symptoms and metabolic imbalance.


4 July 2024 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
JCJia Chen
Jia Chen
XLXuejiao Liu
Xuejiao Liu
SLShuai Lu
Shuai Lu
SMSiliang Man
Siliang Man
LZLiang Zhang
Liang Zhang
XJXieyuan Jiang
Xieyuan Jiang

25 February 2026 in Clinics
Verified
Journal Article
Open access
ZWZhixin Wang
Zhixin Wang
LHLili Huo
Lili Huo
LLLing Lan
Ling Lan
YCYongzeng Chen
Yongzeng Chen
QZQingyao Zuo
Qingyao Zuo
WDWei Deng
Wei Deng
Accumulating evidence suggests maturity onset diabetes of the young (MODY) caused by GCK gene mutations (GCK-MODY) is often misdiagnosed as Gestational Diabetes Mellitus (GDM) in pregnant women. This study investigated the prevalence and diagnostic value of GCK gene mutations in Chinese GDM patients. A retrospective analysis was conducted on 3394 pregnant women undergoing prenatal care or delivery at Beijing Jishuitan Hospital between April and December 2019. GDM was diagnosed in 474 women (14.0%) using the International Association of Diabetes and Pregnancy Study Groups (IADPSG, 2010) criteria via a 75 g Oral Glucose Tolerance Test (OGTT). Among these, 177 GDM patients with fasting blood glucose ≥5.1 mmoL/L underwent targeted GCK gene sequencing. Targeted sequencing identified eight rare GCK variants in nine individuals. None of the variant carriers met definitive diagnostic criteria for GCK-MODY. The prevalence of rare GCK variants in the screened GDM subgroup was 1.9% (9/474). The low prevalence (1.9%) of rare GCK variants and absence of confirmed GCK-MODY cases indicate limited utility of fasting glucose-based screening for GCK-MODY in Chinese GDM populations. These findings highlight challenges in distinguishing GCK-MODY from GDM through conventional glucose thresholds.